Overview

Detailed Summary

Oxygenta Pharmaceutical Limited, formerly S S Organics Ltd, specializes in manufacturing anti-ulcerative and antibacterial drugs, alongside other pharmaceuticals.
The company engages in both contract manufacturing and independent production, supporting its revenue through strategic partnerships.
Oxygenta's production facilities are situated in Medak, Andhra Pradesh, focusing on bulk drugs, including quinolones, antiasthmatic, and anti-inflammatory medications.
Despite operational challenges, such as the 2015 fire accident, Oxygenta has resumed commercial production to stabilize its operations and market position.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 211 Cr
Volatility: High Risk
P/E Ratio: -10.2
Industry P/E: 32.3
PEG Ratio: —
P/B Ratio: —
52W High: 133.50
52W Low: 45.30

Sales CAGR

1Y: 175.73%
3Y: 21.78%
5Y: 51.45%
10Y: 27.33%

Profit CAGR

1Y: -178.16%
3Y: —
5Y: —
10Y: —

ROE

TTM: 46.67%
3Y: 27.08%
5Y: 13.67%
10Y: 14.73%

ROCE

TTM: -53.26%
3Y: -65.93%
5Y: -30.23%
10Y: -52.67%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BDH		366.30	222 Cr	20.23	3.20	1.17	13.80	18.80	11.73
OXYGENTAPH		49.80	211 Cr	-10.16	0.00	0.00	46.67	-53.26	-15.44
SANJIVIN		182.90	209 Cr	28.76	4.67	0.28	16.63	19.07	11.42
TRANSCHEM		177.95	209 Cr	74.15	2.58	0.00	4.68	6.44	3.59
LYKALABS		58.27	208 Cr	-291.35	2.06	0.00	2.03	4.68	-0.20
QUESTLAB		103.95	199 Cr	12.55	2.21	0.00	12.05	12.15	10.18
PARNAXLAB		141.50	184 Cr	12.96	2.04	0.00	12.26	12.71	6.01
Median: 7 Co.	—	141.50	209 Cr	12.96	2.21	0.00	12.26	12.15	6.01

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	13	9.15	11	13	14	33	49	15	14	34
Expenses	15	12	12	14	16	38	51	22	19	38
Operating Profit	-1.98	-2.47	-1.61	-1.78	-2.17	-4.35	-1.68	-6.83	-4.57	-4.08
OPM %	-15.14	-26.99	-15.26	-14.10	-15.49	-13.10	-3.40	-45.14	-31.96	-12.02
Other Income	-0.03	-0.02	0.26	0.02	0.75	0.49	-0.22	0.16	-0.06	0.00
Interest	0.34	0.36	0.59	0.41	0.69	0.39	2.13	0.63	0.95	1.39
Depreciation	0.83	0.69	0.64	0.65	0.66	0.71	-0.23	0.85	0.86	0.86
Profit Before Tax	-3.18	-3.55	-2.59	-2.82	-2.77	-4.96	-3.80	-8.15	-6.44	-6.33
Tax %	0.63	-6.48	409.27	51.42	-2.89	20.77	43.42	25.03	23.45	23.38
Net Profit	-3.16	-3.78	8.02	-1.36	-2.85	-3.93	-2.15	-6.11	-4.93	-4.84
EPS in Rs	-0.69	-0.85	2.21	-0.35	-0.75	1.07	-0.60	-1.65	-1.33	-1.32

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	8.15	13	21	14	52	61	31	40	109	112
Expenses	13	17	23	22	48	59	38	49	119	127
Operating Profit	-4.84	-4.00	-2.04	-7.87	3.84	1.48	-7.12	-9.70	-9.94	-15
OPM %	-59.39	-31.06	-9.96	-57.36	7.39	2.44	-22.97	-24.46	-9.10	-13.44
Other Income	0.62	1.36	0.31	4.02	2.28	0.55	-0.72	0.08	1.04	1.18
Interest	0.60	0.90	0.75	1.09	1.78	0.92	1.49	1.59	1.78	3.84
Depreciation	0.90	0.94	1.02	1.00	1.20	1.59	2.05	2.66	0.82	1.99
Profit Before Tax	-5.72	-4.48	-3.49	-5.94	3.14	-0.49	-11	-14	-12	-20
Tax %	-1.49	-1.08	6.84	2.58	6.81	-24.75	-1.74	74.92	16.19	23.58
Net Profit	-5.81	-4.53	-3.25	-5.79	2.93	-0.61	-12	-3.48	-9.68	-15
EPS in Rs	-1.57	-1.22	-0.88	-1.56	0.79	-0.21	-3.13	-0.82	-0.63	-4.90
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10	10	10	14	14	33	37
Reserves	-32	-38	-42	-45	-51	-48	-49	-60	-54	-62
Borrowings	17	18	18	21	26	48	52	68	57	62
Other Liabilities	25	28	31	35	34	24	14	32	26	46
Total Liabilities	20	19	17	21	19	34	31	54	63	83
Fixed Assets	13	12	12	12	11	16	20	28	29	40
CWIP	0.07	0.43	0.06	0.00	0.00	0.65	0.34	0.00	0.00	0.23
Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Other Assets	6.85	6.14	4.57	9.21	7.15	17	11	26	34	44
Total Assets	20	19	17	21	19	34	31	54	63	83

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.85	0.52	1.28	-7.79	-2.59	-1.62	-1.68	-1.63	-13	2.60
Cash from Investing Activity	-2.08	-0.90	-0.39	-0.56	-0.50	-6.72	-4.94	-9.64	-4.09	-11
Cash from Financing Activity	1.17	0.39	-0.90	8.36	3.19	8.67	6.33	11	17	8.67
Net Cash Flow	-0.06	0.01	-0.01	0.01	0.10	0.33	-0.29	-0.05	-0.01	0.02

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	26.80%	29.73%	29.73%	29.73%	33.69%	53.28%	51.12%	51.12%	57.92%	57.95%	55.93%	56.54%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Public	73.18%	70.25%	70.25%	70.25%	66.29%	46.69%	48.85%	48.85%	42.06%	42.02%	44.04%	43.44%
Total Shareholders	8,987	8,972	9,051	10,102	9,970	10,154	10,111	10,030	10,094	10,179	10,215	10,205

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.